References
- Watts JC, Chandler FW. Evolving concepts of infection by Pneumocystis carinii. Pathol Annu 1991;26:93–138.
- Arend SM, Kroon FP, van’t Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993; an analysis of 78 cases. Arch Intern Med. 1995; 155: 2436–41.
- Masur H, Lane HC, Kovacs JA, Allegra CJ, Edman JC. Pneumocystis pneumonia:From bench to clinic. Ann Intern Med. 1989; 111: 813–26.
- Talseth T, Holdaas H, Albrechtsen D et al. Increasing incidence of Pneumocystis carinii pneumonitis in renal transplant patients. Tranplant Proc. 1988;20:400–1.
- Varthalitis I, Aoun M, Daneau D. MeunierF. Pneumocystis carinii pneumonia in patients with cancer. Cancer. 1993; 71: 481–5.
- Special Report: Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990; 323: 1500–4.
- Saltier FR, Cowan R, Nielsen DM, Ruskin J. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the Acquired Immunodeficiency Syndrome. Ann Intern Med. 1988; 109: 280–7
- Saldana MJ, Mones AM, Martinez GR. The pathology of treated Pneumocystis carinii pneumonia. Semin Diagn Pathol. 1989; 6: 300–12.
- Dummer JS. Pneumocystis carinii infections in transplant recipients. Semin Respir Infect. 1990; 5: 50–7.
- Elinder CG, Andersson J, Bolinder G, Tyden G. Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and/or pancreas transplantation. Transplant Int. 1992; 5: 81–4.
- Kramer MR, Stoehr C, Lewiston NJ, Starnes VA, Theodore J. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation-How effective and for how long ? Transplantation. 1992; 53:586–9.
- Under J. Infection as a complication of heart transplantation. J Heart Transplant. 1988; 7: 390–4.
- Kovacs JA, Hiemenz JW, Macher AM et al. Pneumocystis carinii pneumonia: a comparison between patients with the Acquired Immunodeficiency Syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984; 100: 663–71.
- Katz MH, Baron RB, Grady D. Risk stratification of ambulatory patients suspected of Pneumocystis pneumonia. Arch Intern Med. 1991; 151:105–10.
- USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected will Human Immunodeficiency Virus: a summary. Ann Intern Med. 1996; 124: 348–68.
- Lane HC, Laughon BE, Falloon J, Kovacs JA, Davey RT, Polis MA, Masur H. Recent advances in the management of AIDS-related opportunistic infections. Ann Intern Med. 1994; 120: 945–55.
- Wofsy CB. Use of trimethoprim-sulfamethoxa zole in the treatment of Pneumocystis carinii pneu monitis in patients with Acquired Immunodefi ciency Syndrome. Rev Infect Dis. 1987; 9:184–91
- Kales CP, Murren JR, Torres RA, Crocco JA. Ear ly predictors of in-hospital mortality for Pneumo cystis carinii pneumonia in the Acquired Immuno deficiency Syndrome. Arch Intern Med. 1987 147: 1413–7.
- Mason GR, Hashimoto CH, Dickman PS, Foutty LF, Cobb CJ. Prognostic implications of bronchoalveolar lavage neutrophilia in patients wilh Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis. 1989; 139: 1336–42.
- Wachter RM, Luce IM, Safrin S, Berrios DC, Charlebois E, Scitovsky AA. Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. JAMA. 1995; 273: 230-S.
- Sepkowitz KA, Brown AE, Armstrong D. Pneumocystis carinii pneumonia without Acquired Immunodeficiency Syndrome. Arc/i Intern Med- 1995;155: 1125–8.